HomePCVX • NASDAQ
add
Vaxcyte Inc
Previous close
$91.70
Day range
$90.70 - $92.61
Year range
$48.35 - $121.06
Market cap
11.01B USD
Avg Volume
1.35M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 139.92M | 23.80% |
Net income | -103.12M | -11.29% |
Net profit margin | — | — |
Earnings per share | -0.83 | 8.38% |
EBITDA | -138.14M | -23.09% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.18B | 72.28% |
Total assets | 3.56B | 137.94% |
Total liabilities | 142.11M | 52.25% |
Total equity | 3.42B | — |
Shares outstanding | 124.64M | — |
Price to book | 3.34 | — |
Return on assets | -12.39% | — |
Return on capital | -12.82% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -103.12M | -11.29% |
Cash from operations | -60.71M | -5.49% |
Cash from investing | -917.02M | -4,215.88% |
Cash from financing | 1.52B | 3,020.57% |
Net change in cash | 531.73M | 3,609.86% |
Free cash flow | -65.80M | -51.33% |
About
Founded
2013
Headquarters
Website
Employees
254
